Somatic gene transfer to the pulmonary circulation may be useful in treating pulmonary hypertension, adult respiratory distress syndrome or metastatic disease to the lung. Current generation adenoviral vectors may be useful for such purposes but their gene transfer efficiency is modest after i.v. administration and concerns remain regarding immune and inflammatory responses to these constructs limiting their potential use in repetitive dosage regimens. Accordingly, non-viral vectors represent a rational alternative. The applicants have recently reported the design of a cationic lipid/protamine/DNA complex (LPD) that had physiochemical properties considerably different from cationic lipid/DNA complexes and whose behavior was more similar to a synthetic virus-like particles. LPD has a core of protamine-condensed DNA coated with a lipidic shell with a size of 50-100 nm. It is remarkably efficient in transferring reporter genes to the pulmonary circulation of intact mice but is associated with an inflammatory response that may contribute to transient gene expression and refractoriness to repeated injections at frequent intervals. To elucidate the mechanism of LPD-induced toxicity, the applicants have shown in preliminary studies that i.v. administration of LPD induces a high level of proinflammatory cytokine production which not only cause toxicity to experimental animals but also inhibit transgene expression. They have further shown that unmethylated CpG sequences in the plasmid DNA play and important role in the induction of cytokines. Intravenous administration of short, linear DNA fragments formulated in LPD leads to efficient lung transfection but is associated with significantly lower levels of cytokine production. The applicants will follow up these important findings by focusing our efforts in the following three aims.
Aim 1, to further determine the molecular mechanism by which plasmid DNA contributes to LPD-induced inflammatory response and reduced transgene expression. A strategy of using short, synthetic genes to reduce toxicity will also be investigated.
Aim 2, to further define the pathophysiologic response of pulmonary circulation that modifies LPD-mediated somatic gene transfer.
Aim 3, to engineer LPD complexes with targeting ligands to pulmonary endothelium to improve the efficiency of gene (plasmid DNA or synthetic genes) delivery to pulmonary endothelium while maintaining the non-specific interactions with immune cells. These studies will promise to improve the efficiency of gene transfer by LPD and reduce the untoward toxicity.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
1R01HL063080-01A1
Application #
6130567
Study Section
Special Emphasis Panel (ZRG1-RAP (01))
Project Start
2000-04-03
Project End
2005-03-31
Budget Start
2000-04-03
Budget End
2001-03-31
Support Year
1
Fiscal Year
2000
Total Cost
$256,148
Indirect Cost
Name
University of Pittsburgh
Department
Pharmacology
Type
Schools of Pharmacy
DUNS #
053785812
City
Pittsburgh
State
PA
Country
United States
Zip Code
15213
Zhang, Peng; Huang, Yixian; Makhov, Alexander M et al. (2013) Characterization of spherulites as a lipidic carrier for low and high molecular weight agents. Pharm Res 30:1525-35
Kuruba, Ramalinga; Wilson, Annette; Gao, Xiang et al. (2009) Targeted delivery of nucleic-acid-based therapeutics to the pulmonary circulation. AAPS J 11:23-30
Li, Jiang; Wilson, Annette; Gao, Xiang et al. (2009) Coordinated regulation of dimethylarginine dimethylaminohydrolase-1 and cationic amino acid transporter-1 by farnesoid X receptor in mouse liver and kidney and its implication in the control of blood levels of asymmetric dimethylarginine. J Pharmacol Exp Ther 331:234-43
Zhang, Qiuhong; He, Fengtian; Kuruba, Ramalinga et al. (2008) FXR-mediated regulation of angiotensin type 2 receptor expression in vascular smooth muscle cells. Cardiovasc Res 77:560-9
He, Fengtian; Li, Jiang; Mu, Ying et al. (2006) Downregulation of endothelin-1 by farnesoid X receptor in vascular endothelial cells. Circ Res 98:192-9
Wilson, Annette; He, Fengtian; Li, Jiang et al. (2005) Targeted delivery of therapeutic oligonucleotides to pulmonary circulation. Adv Genet 54:21-41
Wilson, Annette; Zhou, Wen; Champion, Hunter C et al. (2005) Targeted delivery of oligodeoxynucleotides to mouse lung endothelial cells in vitro and in vivo. Mol Ther 12:510-8
Ma, Zheng; Li, Jiang; He, Fengtian et al. (2005) Cationic lipids enhance siRNA-mediated interferon response in mice. Biochem Biophys Res Commun 330:755-9
Ma, Zheng; Li, Jiang; Yang, Lijuan et al. (2004) Inhibition of LPS- and CpG DNA-induced TNF-alpha response by oxidized phospholipids. Am J Physiol Lung Cell Mol Physiol 286:L808-16
Yang, Lijuan; Li, Jiang; Zhou, Wen et al. (2004) Targeted delivery of antisense oligodeoxynucleotides to folate receptor-overexpressing tumor cells. J Control Release 95:321-31

Showing the most recent 10 out of 21 publications